JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.7% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 8.85% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Industrials | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
VolitionRx Ltd
VNRX
$7.48M
| $233K | ﹤0.01% |
+2,070
| New | +$165K |
|
4377
Viridian Therapeutics
VRDN
$2.52B
| $233K | ﹤0.01% |
21,290
-2,660
| -11% | -$58.8K |
|
|
NVEE
4378
DELISTED
NV5 Global
NVEE
| $232K | ﹤0.01% |
13,580
-19,480
| -59% | -$354K |
|
4379
iShares MSCI Europe Small-Cap ETF
IEUS
$184M
| $231K | ﹤0.01% |
4,731
| – | – |
|
4380
OneSpaWorld
OSW
$2.73B
| $231K | ﹤0.01% |
14,890
+2,415
| +19% | +$37.9K |
|
4381
York Water
YORW
$533M
| $231K | ﹤0.01% |
5,273
+687
| +15% | +$25.9K |
|
|
BNFT
4382
DELISTED
Benefitfocus, Inc.
BNFT
| $231K | ﹤0.01% |
9,714
-16,644
| -63% | -$427K |
|
4383
Veritone
VERI
$139M
| $230K | ﹤0.01% |
64,387
-107,510
| -63% | -$615K |
|
4384
Geron
GERN
$1B
| $229K | ﹤0.01% |
172,193
-492,774
| -74% | -$660K |
|
4385
PLDT
PHI
$4.21B
| $229K | ﹤0.01% |
10,420
+3,280
| +46% | +$73.3K |
|
|
AAWW
4386
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $229K | ﹤0.01% |
9,084
-67,589
| -88% | -$2.21M |
|
4387
NRC Health Common Stock
NRC
$458M
| $228K | ﹤0.01% |
3,944
+640
| +19% | +$39.7K |
|
|
JPEU
4388
DELISTED
JPMorgan Diversified Return Europe Equity ETF
JPEU
| $228K | ﹤0.01% |
4,130
| – | – |
|
|
PKD
4389
DELISTED
Parker Drilling Company
PKD
| $228K | ﹤0.01% |
12,066
+9,505
| +371% | +$163K |
|
4390
CALL
National Beverage
FIZZ
$2.93B
| $226K | ﹤0.01% |
+10,200
| New | +$220K |
|
4391
The RMR Group
RMR
$342M
| $226K | ﹤0.01% |
4,976
-24,938
| -83% | -$1.17M |
|
4392
Alaunos Therapeutics
TCRT
$4.88M
| $225K | ﹤0.01% |
351
+57
| +19% | +$45.2K |
|
4393
Weyco Group
WEYS
$436M
| $225K | ﹤0.01% |
9,919
-11,893
| -55% | -$296K |
|
|
TRQ
4394
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $225K | ﹤0.01% |
47,357
+45,567
| +2,546% | +$274K |
|
4395
Clearfield
CLFD
$395M
| $224K | ﹤0.01% |
18,900
+15,824
| +514% | +$194K |
|
4396
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
| $223K | ﹤0.01% |
11,128
-19,649
| -64% | -$384K |
|
4397
Civeo
CVEO
$347M
| $223K | ﹤0.01% |
14,601
+12,843
| +731% | +$227K |
|
4398
Horizon Bancorp
HBNC
$1.06B
| $223K | ﹤0.01% |
12,848
+2,596
| +25% | +$43.2K |
|
4399
ProShares VIX Short-Term Futures ETF
VIXY
$190M
| $223K | ﹤0.01% |
143
-695
| -83% | -$1.14M |
|
|
ALNA
4400
DELISTED
Allena Pharmaceuticals
ALNA
| $223K | ﹤0.01% |
56,579
+9,678
| +21% | +$41.5K |
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,787 increased, 1,863 reduced and 427 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 427 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.